Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab
A registry study assessing compliance among Colombian rheumatoid arthritis patients treated with golimumab has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial results for NNC109-0012 in active rheumatoid arthritis were reported. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis [Phase 2]
Phase 2 multiple-dose trial of the investigational compound NNC 0151-0000-0000 in subjects with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 study assessing the safety and tolerability of an anti-IL-20 antibody in healthy volunteers and in patients with rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis [Phase 1]
This clinical trial update summarizes the safety and tolerability findings of an anti-IL-20 antibody in subjects with rheumatoid arthritis i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects [Phase 1]
Phase 1 dose-escalation study of an anti-C5aR antibody in healthy subjects has completed, reporting safety and pharmacokinetics data.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial evaluating whether the anti-IL-6 monoclonal antibody tocilizumab influences cardiovascular risk in rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis [Phase 1]
A first-in-man Phase 1 study evaluating safety and pharmacology of NNC114-0005 in healthy subjects and individuals with rheumatoid arthritis…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis [Phase 1]
Phase 1 safety and tolerability evaluation of NNC0114-0006 at increasing doses in adults with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis [NA]
A completed clinical trial comparing patient-reported outcomes collected at home via PC/tablet with those entered on a hospital touch-screen…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial evaluating NNC0114-0006 in active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Etanercept in Rheumatoid Arthritis and Vascular Inflammation [Phase 4]
A Phase 4 clinical trial evaluating etanercept for rheumatoid arthritis and vascular inflammation has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers [Phase 1]
A multicenter Phase 1 postmarketing study evaluating the concentration of certolizumab pegol (Cimzia) in mature breast milk of lactating mot…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis
A non-interventional study of RAYOS in adults with rheumatoid arthritis has completed, and results were posted on 2017-02-03.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease [Phase 3]
Phase 3 trial update assessing PPAR-gamma agonists in rheumatoid arthritis with cardiovascular disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: The Health Log: A Randomized Clinical Trial [NA]
A randomized clinical trial evaluating treatment for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis [Phase 3]
This document reports results from a long-term extension study assessing the safety of tocilizumab (RoActemra/Actemra) in participants with …
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
An observational study update comparing Rituximab and other TNF inhibitors in rheumatoid arthritis patients who did not respond adequately t…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]
A Phase 3 trial comparing SB5 to Humira in patients with moderate to severe rheumatoid arthritis who are on methotrexate, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: The Effects of a Six-week Exercise Programme Undertaken by Women With Rheumatoid Arthritis [NA]
This completed clinical trial assessed the effects of a six-week exercise program in women with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
This document reports the completed results of a long-term use survey evaluating intravenous abatacept (ORENCIA) 250 mg in patients with rhe…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
Clinical trial update noting completion of a Use-Results Survey for ORENCIA (abatacept) 125 mg subcutaneous injection in rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy [Phase 1]
Phase 1 exploratory trial evaluating changes in synovial immune responses after BMS-188667 therapy in active rheumatoid arthritis patients o…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System
A completed prospective study evaluated clinical outcomes of knee arthroplasty using the VERASENSE Knee System.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis [Phase 3]
Phase 3 randomized, double-blind study evaluating certolizumab pegol plus methotrexate versus methotrexate alone in DMARD-naïve adults with …